Labellarte Michael J, Crosson Jane E, Riddle Mark A
Division of Child and Adolescent Psychiatry, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287-3325, USA.
J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):642-50. doi: 10.1097/01.CHI.0000046860.56865.25.
To consider the relevance of prolonged QTc (QT interval corrected for rate) to pediatric psychopharmacology.
The authors reviewed publications on QTc prolongation and publications on sudden death in Medline from 1968 to November 2002.
The search yielded more than 20,000 publications. Review manuscripts with clinical recommendations outnumber the few pediatric studies of QTc duration during treatment. Most reviews have been published in the past 5 years, during a time when the Food and Drug Administration restricted five psychotropic medications because of QTc prolongation (sertindole: not approved; thioridazine, mesoridazine, and droperidol: black-box warning; and ziprasidone: bolded warning) and nine somatic medications because of QTc prolongation.
Pretreatment screening, careful selection of psychotropic and/or somatic medication combinations, and recognition of QTc prolongation in electrocardiographic tracings during treatment with medications that prolong QTc are important components of clinical practice.
探讨校正心率后的QT间期延长(QTc)与儿科精神药理学的相关性。
作者检索了1968年至2002年11月期间Medline上关于QTc延长及猝死的相关文献。
检索得到20000多篇文献。带有临床建议的综述性文稿数量超过了少数关于治疗期间QTc时长的儿科研究。大多数综述发表于过去5年,在此期间,美国食品药品监督管理局因QTc延长限制了5种精神药物(舍吲哚:未获批;硫利达嗪、美索达嗪和氟哌利多:黑框警告;齐拉西酮:加粗警告)以及9种躯体药物。
治疗前筛查、谨慎选择精神药物和/或躯体药物组合,以及在用可延长QTc的药物治疗期间识别心电图中的QTc延长,是临床实践的重要组成部分。